Academic Journal

Double-negative-2 B cells are the major synovial plasma cell precursor in rheumatoid arthritis

التفاصيل البيبلوغرافية
العنوان: Double-negative-2 B cells are the major synovial plasma cell precursor in rheumatoid arthritis
المؤلفون: Elinor Wing, Catherine Sutherland, Katherine Miles, David Gray, Carl S. Goodyear, Thomas D. Otto, Stefan Breusch, Graeme Cowan, Mohini Gray
المصدر: Frontiers in Immunology, Vol 14 (2023)
بيانات النشر: Frontiers Media S.A., 2023.
سنة النشر: 2023
المجموعة: LCC:Immunologic diseases. Allergy
مصطلحات موضوعية: rheumatoid arthritis, double-negative-2 (DN2) B cells, antibody secreting cells, synovium, single-cell sequencing, Immunologic diseases. Allergy, RC581-607
الوصف: B cells are key pathogenic drivers of chronic inflammation in rheumatoid arthritis (RA). There is limited understanding of the relationship between synovial B cell subsets and pathogenic antibody secreting cells (ASCs). This knowledge is crucial for the development of more targeted B-cell depleting therapies. While CD11c+ double-negative 2 (DN2) B cells have been suggested as an ASC precursor in lupus, to date there is no proven link between the two subsets in RA. We have used both single-cell gene expression and BCR sequencing to study synovial B cells from patients with established RA, in addition to flow cytometry of circulating B cells. To better understand the differentiation patterns within the diseased tissue, a combination of RNA-based trajectory inference and clonal lineage analysis of BCR relationships were used. Both forms of analysis indicated that DN2 B cells serve as a major precursors to synovial ASCs. This study advances our understanding of B cells in RA and reveals the origin of pathogenic ASCs in the RA synovium. Given the significant role of DN2 B cells as a progenitor to pathogenic B cells in RA, it is important to conduct additional research to investigate the origins of DN2 B cells in RA and explore their potential as therapeutic targets in place of the less specific pan-B cells depletion therapies currently in use.
نوع الوثيقة: article
وصف الملف: electronic resource
اللغة: English
تدمد: 1664-3224
Relation: https://www.frontiersin.org/articles/10.3389/fimmu.2023.1241474/full; https://doaj.org/toc/1664-3224
DOI: 10.3389/fimmu.2023.1241474
URL الوصول: https://doaj.org/article/7be81bbfafaa40f7b7970a61171c4912
رقم الانضمام: edsdoj.7be81bbfafaa40f7b7970a61171c4912
قاعدة البيانات: Directory of Open Access Journals
الوصف
تدمد:16643224
DOI:10.3389/fimmu.2023.1241474